✦ LIBER ✦

ChemInform Abstract: Development of Tau Aggregation Inhibitors for Alzheimer′s Disease.

✍ Scribed by Bruno Bulic; Marcus Pickhardt; Boris Schmidt; Eva-Maria Mandelkow; Herbert Waldmann; Eckhard Mandelkow

Publisher: John Wiley and Sons
Year: 2009
Weight: 15 KB
Volume: 40
Category: Article
ISSN: 0931-7597
DOI: 10.1002/chin.200920218

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

ChemInform Abstract: Amyloid Aggregates,

ChemInform Abstract: Amyloid Aggregates, Presenilins, and Alzheimer′s Disease

✍ Ralf Baumeister; Stefan Eimer 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 23 KB

Development of antiinflammatory therapy

Development of antiinflammatory therapy for Alzheimer's disease

✍ Paul S. Aisen 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 82 KB

ChemInform Abstract: Discovery and Devel

ChemInform Abstract: Discovery and Development of Donepezil Hydrochloride for Treatment of Alzheimer′s Disease

✍ H. SUGIMOTO 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 25 KB

ChemInform Abstract: Discovery and Devel

ChemInform Abstract: Discovery and Development of Donepezil Hydrochloride for the Treatment of Alzheimer′s Disease

✍ Hachiro Sugimoto; Yoshiharu Yamanishi; Hiroo Ogura; Youichi Iimura; Kiyomi Yamat 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 24 KB 👁 1 views

Reimbursement of acetilcholinesterase in

Reimbursement of acetilcholinesterase inhibitors for Alzheimer's Disease in Europe

✍ Giovanni B. Frisoni 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB 👁 1 views

Delaying the onset and progression of Alzheimer's disease (AD) is a tremendously relevant issue in western countries. It has been estimated that delaying the onset of AD-related disability by 6 months might lead to 100,000 fewer persons with AD-related disability after 10 years in the United States

γ-secretase inhibitors for the treatment

γ-secretase inhibitors for the treatment of Alzheimer's disease

✍ Wen-Lian Wu; Lili Zhang 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 105 KB